Durvalumab is an IV drug that boosts the immune system’s ability to detect and kill cancer cells. It’s used to treat a range ...

Head and neck cancer patients went disease-free for five years, compared to half that time for people undergoing standard ...

Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Adding Roche's immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon cancer had spread ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Drugs that boost the body's immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...